Dietary Supplementation of Black Rice Anthocyanin Extract Regulates Cholesterol Metabolism and Improves Gut Microbiota Dysbiosis in C57BL/6J Mice Fed a High‐Fat and Cholesterol Diet

Molecular Nutrition and Food Research - Tập 64 Số 8 - 2020
Hao Wang1, Dong Liu1, Yanglin Ji1, Yaojie Liu1, Lin Xu2, Yatu Guo3
1State Key Laboratory of Food Nutrition and Safety Tianjin University of Science & Technology Tianjin 300457 China
2Pathology Department, Tianjin Municipal Public Security Hospital, Tianjin, 300042 China
3Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin, 300384 China

Tóm tắt

ScopeThis study explores the beneficial effects of dietary supplementation of black rice anthocyanin extract (BRAE) on cholesterol metabolism and gut dysbiosis.Methods and resultsC57BL/6J mice are grouped into the normal chow diet group (NCD), the high‐fat and the cholesterol diet group (HCD), and three treatment groups feeding HCD supplemented with various dosage of BRAE for 12 weeks. Results reveal that BRAE alleviates the increased body weight, serum triglyceride (TG), total cholesterol (TC), non‐high‐density lipoprotein cholesterol levels (non‐HDL‐C), and increased fecal sterols excretion and caecal short‐chain fatty acids (SCFAs) concentration in HCD‐induced hypercholesterolemic mice. Moreover, BRAE decreases hepatic TC content through the fundamental regulation of body energy balance gene, adenosine 5′‐monophosphate activated protein kinase α (AMPKα). Meanwhile, BRAE improves the genes expression involved in cholesterol uptake and efflux, and preserves CYP7A1, ATP‐binding cassette subfamily G member 5/8 mRNA expression, and the relative abundance of gut microbiota. Additionally, the antibiotic treatment experiment indicates that the beneficial effects of BRAE in reducing hypocholesterolemia risk largely depends on the gut microbiota homeostasis.ConclusionBRAE supplement could be a beneficial treatment option for preventing HCD‐induced hypocholesterolemia and related metabolic syndromes.

Từ khóa


Tài liệu tham khảo

10.1038/s41386-019-0437-1

10.1007/s11936-010-0080-y

10.1016/j.jff.2019.03.043

10.1016/j.foodchem.2015.09.113

10.1016/j.jplph.2019.02.011

10.1039/C9FO00242A

10.1016/j.foodres.2015.06.043

A. Morais C., 2014, Mediators Inflamm., 987927

10.1021/jf501808a

10.1002/biof.1365

10.1271/bbb.70581

10.1021/jf1007665

10.1016/j.redox.2019.101269

10.1186/1743-7075-9-27

10.2337/db07-1403

10.2353/ajpath.2006.050617

Zhang X.‐Y., 2018, Molecules, 23

10.1039/C7FO01490B

10.1080/09168451.2017.1372178

10.1096/fj.07-9574LSF

10.1016/S0021-9258(18)64849-5

10.1111/jfbc.12744

10.1111/j.1365-2672.2004.02409.x

10.1128/AEM.61.8.3069-3075.1995

10.1039/C8FO02271B

10.1016/j.jff.2019.05.032

Zhang L., 2019, FASEB J.

10.1021/acs.jafc.8b05770

10.1097/00004836-200603000-00015

10.1126/scitranslmed.3005687

10.1039/C7FO00449D

10.5607/en.2018.27.2.129

10.1016/j.jff.2015.12.007

10.1016/j.tem.2017.05.004

10.1016/j.bmcl.2013.05.030

10.1016/j.jsbmb.2019.03.028

10.1101/gad.9.9.1033

10.1016/j.bbadis.2017.09.019

10.1039/C9FO01616C

10.1016/j.phymed.2017.11.008

10.1016/j.foodchem.2015.09.048

10.4049/jimmunol.1700105

10.1038/nature05414

10.1073/pnas.1219451110

10.1016/j.jff.2019.103437

10.1021/acs.jafc.6b00586

10.1128/IAI.01104-10

10.3109/03602532.2014.978080

10.1002/mnfr.200700092

10.1021/acs.jafc.5b00963

10.1021/jf025947u

10.1021/jf001246q

10.1093/jn/132.6.1249

10.1080/10715760600758522